why choose us

First received: December 12, 2022

Clinical Trial: A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Heart Failure With Reduced Ejection Fraction

Study Type: INTERVENTIONAL


Official Title: A Phase IV Interventional Post Approval Trial to Investigate Effectiveness and Safety of Vericiguat Therapy in Indian Patients With Chronic Heart Failure With Reduced Ejection Fraction After a Worseni

Brief Summary: Researchers are looking for a better way to treat people who have chronic heart failure with reduced ejection fraction (HFrEF).HFrEF is a long-term condition where the left side of the heart does not pump blood out to the body as well as it should.Blood and fluid may collect in the lungs, blood vessels, and tissues causing shortness of breath or tiredness.Over time, heart failure can lead to other serious medical conditions that may result in hospital stays and death.Despite various available treatments for…

Read more